Patents by Inventor Emiliangelo Ratti

Emiliangelo Ratti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL USES
    Publication number: 20190216806
    Abstract: This invention relates to the new use of the compound (I) or pharmaceutical acceptable salts thereof and pharmaceutical compositions containing it for the treatment of pruritus and to combinations for such a use.
    Type: Application
    Filed: March 27, 2019
    Publication date: July 18, 2019
    Applicant: NeRRe Therapeutics Limited
    Inventors: Emiliangelo Ratti, Michael Trower
  • NOVEL USES
    Publication number: 20170143711
    Abstract: This invention relates to the new use of the compound (I) or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing it for the treatment of pruritus and to combinations for such a use.
    Type: Application
    Filed: February 7, 2017
    Publication date: May 25, 2017
    Inventors: Emiliangelo Ratti, Michael Trower
  • Uses of orvepitant
    Patent number: 9603849
    Abstract: This invention relates to the new use of the compound (I) or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing it for the treatment of pruritus and to combinations for such a use.
    Type: Grant
    Filed: October 9, 2013
    Date of Patent: March 28, 2017
    Assignee: NERRE THERAPEUTICS LIMITED
    Inventors: Emiliangelo Ratti, Michael Trower
  • NOVEL USES
    Publication number: 20150238486
    Abstract: This invention relates to the new use of the compound (I) or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing it for the treatment of pruritus and to combinations for such a use.
    Type: Application
    Filed: October 9, 2013
    Publication date: August 27, 2015
    Inventors: Emiliangelo Ratti, Michael Trower
  • Use of a p38 kinase inhibitor for treating psychiatric disorders
    Patent number: 7989479
    Abstract: The use of 6-(S-Cyclopropylcarbamoyl-S-fluoro-2-methyl-phenyl)-N-(2,2-dimethylproyl)-nicotinamide, which is known in the art as a p38 kinase inhibitor in the treatment or prophlaxis of one or more psychiatric disorders.
    Type: Grant
    Filed: June 13, 2007
    Date of Patent: August 2, 2011
    Assignee: GlaxoSmithKline LLC
    Inventors: Mauro Corsi, Isidore Faiferman, Emilio Merlo Pich, Emiliangelo Ratti, Paul Bryan Wren
  • Composition Comprising An NK-1 Receptor Antagonist And An SSRI For The Treatment Of Tinnitus And Hearing Loss
    Publication number: 20100317666
    Abstract: The present invention relates to methods for treating a subject suffering from tinnitus, hearing loss, or tinnitus and hearing loss comprising administering to the subject an effective amount of an NK1 receptor antagonist alone, or in combination with an effective amount of a selective serotonin reuptake inhibitor. Compositions and pharmaceutical formulations are also provided.
    Type: Application
    Filed: October 18, 2007
    Publication date: December 16, 2010
    Inventors: Soren Rahn Christensen, Emilio Merlo Pich, Emiliangelo Ratti, Tadataka Yamada
  • Novel Compounds
    Publication number: 20100144755
    Abstract: Novel substituted 2,4,8-trisubstituted 8H-pyrido[2,3-d]pyrimidin-7-one containing compounds and compositions, and their use use in therapy as CSBP/RK/p38 kinase inhibitors.
    Type: Application
    Filed: June 15, 2007
    Publication date: June 10, 2010
    Applicant: Glaxo Group Limited
    Inventors: Mauro Corsi, Isidore Faiferman, Emilio Merlo-Pich, Emiliangelo Ratti, Paul Bryan Wren
  • "NOVEL COMPOUNDS"
    Publication number: 20100069409
    Abstract: Novel substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, and 1,5,7-trisubstituted-3,4-dihydro-pyrimido[4,5-d]pyrimidin-2-(M)-one compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors.
    Type: Application
    Filed: June 15, 2007
    Publication date: March 18, 2010
    Applicant: GLAXO GROUP LIMITED
    Inventors: Mauro Corsi, Isidore Faiferman, Emilio Merlo-Pich, Emiliangelo Ratti, Paul Bryan Wren
  • Use of a p38 Kinase Inhibitor for Treating Psychiatric Disorders
    Publication number: 20100016377
    Abstract: The use of 6-(S-Cyclopropylcarbamoyl-S-fluoro-2-methyl-phenyl)-N-(2,2-dimethylproyl)-nicotinamide, which is known in the art as a p38 kinase inhibitor in the treatment or prophlaxis of one or more psychiatric disorders.
    Type: Application
    Filed: June 13, 2007
    Publication date: January 21, 2010
    Inventors: Mauro Corsi, Isidore Faiferman, Emilio Merlo Pich, Emiliangelo Ratti, Paul Bryan Wren
  • NOVEL COMPOUNDS
    Publication number: 20090318424
    Abstract: Novel substituted 1,5,7-trisubstituted-3,4-dihydro-pyrimido[4,5-d]pyrimidin-2-(1H)-one compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors.
    Type: Application
    Filed: June 15, 2007
    Publication date: December 24, 2009
    Inventors: Mauro Corsi, Isidore Faiferman, Emilio Merlo-Pich, Emiliangelo Ratti, Paul Bryan Wren
  • Use of Cyclooxygenase-2 Inhibitors for the Treatment of Depressive Disorders
    Publication number: 20070270428
    Abstract: The invention concerns the use of compounds of formula (I), (II) and (III): which are COX-2 (cyclooxygenase-2) inhibitors, and pharmaceutically acceptable salts or solvates thereof, for the treatment of depressive disorders in combination with an effective amount of a second component which is a selective serotonin reuptake inhibitor.
    Type: Application
    Filed: November 17, 2004
    Publication date: November 22, 2007
    Inventors: James Hagan, Emiliangelo Ratti, Carol Routledge
  • Medicament
    Publication number: 20070219247
    Abstract: This invention provides the use of the compound [2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)]-([2S,3S]-2-phenyl-piperidin-3-yl)-amine, pharmaceutically acceptable salts or solvates thereof and pharmaceutical compositions containing them for the manufacture of a medicament for the treatment or prevention of Posttraumatic Stress Disorder (PTSD).
    Type: Application
    Filed: April 21, 2005
    Publication date: September 20, 2007
    Inventor: Emiliangelo Ratti
  • Tricyclic carbapenem compounds
    Patent number: 6531466
    Abstract: A compound of formula (I), salts and metabolically labile esters thereof, wherein R represents optionally substituted aryl or heteroaryl group; A represents a propylene chain or A is a chain of 3 members one of which is selected from an oxygen or sulphur atom or the group NH or a substituted derivative thereof and the other two members are methylene groups, having antibacterial activity, processes for their preparation and to their use in medicine.
    Type: Grant
    Filed: February 13, 2001
    Date of Patent: March 11, 2003
    Assignee: GlaxoSmithKline SpA
    Inventors: Tino Rossi, Daniele Andreotti, Giovanna Tedesco, Luca Tarsi, Emiliangelo Ratti, Aldo Feriani, Domenica Antonia Pizzi, Giovanni Gaviraghi, Stefano Biondi, Gabriella Finizia
  • Use of cck-b receptor antagonists for the treatment of sleep disorders
    Patent number: 6413930
    Abstract: The use of CCK-B antagonists for the treatment of sleep disorders.
    Type: Grant
    Filed: April 10, 1997
    Date of Patent: July 2, 2002
    Assignee: Glaxo Wellcome Spa
    Inventors: Emiliangelo Ratti, David Gordon Trist, Giovanni Gaviraghi, Francesco Crespi, Angelo Mario Reggiani
  • Tricyclic carbapenem compounds
    Publication number: 20010047094
    Abstract: A compound of formula (1), salts and metabolically labile esters thereof, wherein R represents optionally substituted aryl or heteroaryl group; A represents a propylene chain or A is a chain of 3 members one of which is selected from an oxygen or sulphur atom orthe group NH or a substituted derivative thereof and the other two members are methylene groups, having antibacterial activity, processes for their preparation and to their use in medicine.
    Type: Application
    Filed: February 13, 2001
    Publication date: November 29, 2001
    Applicant: Glaxo Wellcome SpA
    Inventors: Tino Rossi, Daniele Andreotti, Giovanna Tedesco, Luca Tarsi, Emiliangelo Ratti, Aldo Feriani, Domenica Antonia Pizzi, Giovari Gaviraghi, Stefano Biondi, Gabriella Finizia